Grupo Fleury
Fernando Lopes Alberto, appointed to the position of Vice Chairman of the Board of Directors, is a doctor graduated from the Ribeirão Preto School of Medicine at USP. He completed a medical residency in Hematology, Hemotherapy and Bone Marrow Transplant at the same institution and a doctorate in Clinical Medicine from the Faculty of Medical Sciences at UNICAMP. From 1998 to 2000, he worked as a physician and collaborating researcher at the UNICAMP Blood Center, performing assistance and academic activities, with 25 papers published in indexed international journals and elected for three years an honored professor in the group of medical graduates. He worked at Fleury as a medical advisor (Molecular Biology and Hematology) until 2008, when he moved to Fleury‘s Information Technology area, working for two years as a project manager. In 2010, he took over the management of the Hospitals business area. In 2011 he completed an International Executive MBA offered by a consortium of five business schools (FGV / Brazil; EGADE / Mexico; UNC / USA; RSM / Netherlands; CUHK / Hong Kong: OneMBA). In 2015, he took the IBGC Board of Directors‘ training course and, in the same year, he became a professor at EAESP / FGV, co-responsible for two disciplines of the Professional Master in Competitiveness Management, in addition to advising master students. He is currently a member of the Board of Directors Committee and coordinator of the Health Committee, both of the IBGC. Appointed in 2017 to the Board of Directors of Grupo Fleury, he was subsequently appointed to the vice-chairman of the collegiate, a position he currently holds.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.